Supplemental material
General Xenobiochemistry
Understanding metabolism related differences in ocular efficacy of MGV354
Jennifer L. Dumouchela Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Cambridge, MA, USACorrespondence[email protected]
https://orcid.org/0000-0001-9954-2149
https://orcid.org/0000-0001-9954-2149, Upendra A. Argikara Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Cambridge, MA, USACorrespondence[email protected]
https://orcid.org/0000-0002-0939-0813
https://orcid.org/0000-0002-0939-0813, Christopher M. Adamsb Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, MA, USAhttps://orcid.org/0000-0002-5246-884X
https://orcid.org/0000-0002-5246-884X, Ganesh Prasannac Ophthalmology, Novartis Institutes for BioMedical Research, Cambridge, MA, USAhttps://orcid.org/0000-0001-6420-270X
https://orcid.org/0000-0001-6420-270X, Takeru Eharab Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, MA, USAhttps://orcid.org/0000-0002-4889-204X
https://orcid.org/0000-0002-4889-204X, Sean Kima Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Cambridge, MA, USAhttps://orcid.org/0000-0003-1184-8771
https://orcid.org/0000-0003-1184-8771, & show all